Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rosiglitazone and cardiovascular risk.

× No keyword cloud information.

7 in total

Review 1. Rosiglitazone and cardiovascular risk.

Authors: Sanjay Kaul; George A Diamond
Journal: Curr Atheroscler Rep Date: 2008-10 Impact factor: 5.113

2. Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event.

Authors: Fiona C Warren; Keith R Abrams; Su Golder; Alex J Sutton
Journal: BMC Med Res Methodol Date: 2012-05-03 Impact factor: 4.615

3. Impact of rosiglitazone meta-analysis on use of glucose-lowering medications.

Authors: Richard L Morrow; Greg Carney; James M Wright; Ken Bassett; Jenny Sutherland; Colin R Dormuth
Journal: Open Med Date: 2010-03-16

Review 4. Impact of data transparency: Scientific publications.

Authors: Mohit Joshi; Payal Bhardwaj
Journal: Perspect Clin Res Date: 2018 Jan-Mar

5. Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.

Authors: Joshua D Wallach; Kun Wang; Audrey D Zhang; Deanna Cheng; Holly K Grossetta Nardini; Haiqun Lin; Michael B Bracken; Mayur Desai; Harlan M Krumholz; Joseph S Ross
Journal: BMJ Date: 2020-02-05

6. Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches.

Authors: Jan O Friedrich; Joseph Beyene; Neill K J Adhikari
Journal: BMC Res Notes Date: 2009-01-10

7. Simpson's paradox visualized: the example of the rosiglitazone meta-analysis.

Authors: Gerta Rücker; Martin Schumacher
Journal: BMC Med Res Methodol Date: 2008-05-30 Impact factor: 4.615

7 in total